Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |